| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO3A SMCHD1 KIF1B SMARCA1 KIF28P MCM7 DHX32 ATP11A DDX20 RUVBL2 TOP2B DYNC1I1 KIF1C | 2.80e-06 | 614 | 88 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | structural constituent of muscle | 3.81e-05 | 43 | 88 | 4 | GO:0008307 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.41e-04 | 441 | 88 | 9 | GO:0016887 | |
| GeneOntologyMolecularFunction | phospholipid binding | 1.48e-04 | 548 | 88 | 10 | GO:0005543 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.75e-04 | 118 | 88 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | MHC class II protein complex binding | 2.24e-04 | 27 | 88 | 3 | GO:0023026 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 2.59e-04 | 70 | 88 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | actin filament binding | 5.04e-04 | 227 | 88 | 6 | GO:0051015 | |
| GeneOntologyMolecularFunction | helicase activity | 6.72e-04 | 158 | 88 | 5 | GO:0004386 | |
| GeneOntologyMolecularFunction | MHC protein complex binding | 7.81e-04 | 41 | 88 | 3 | GO:0023023 | |
| GeneOntologyMolecularFunction | CD4 receptor binding | 1.03e-03 | 11 | 88 | 2 | GO:0042609 | |
| GeneOntologyMolecularFunction | MHC class II receptor activity | 1.03e-03 | 11 | 88 | 2 | GO:0032395 | |
| GeneOntologyMolecularFunction | peptide antigen binding | 1.32e-03 | 49 | 88 | 3 | GO:0042605 | |
| GeneOntologyMolecularFunction | profilin binding | 1.45e-03 | 13 | 88 | 2 | GO:0005522 | |
| GeneOntologyMolecularFunction | myosin II binding | 1.45e-03 | 13 | 88 | 2 | GO:0045159 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 1.78e-03 | 507 | 88 | 8 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 1.78e-03 | 507 | 88 | 8 | GO:0030695 | |
| GeneOntologyBiologicalProcess | MHC class II protein complex assembly | 3.77e-05 | 16 | 86 | 3 | GO:0002399 | |
| GeneOntologyBiologicalProcess | peptide antigen assembly with MHC class II protein complex | 3.77e-05 | 16 | 86 | 3 | GO:0002503 | |
| GeneOntologyBiologicalProcess | cardiac muscle thin filament assembly | 5.14e-05 | 3 | 86 | 2 | GO:0071691 | |
| GeneOntologyBiologicalProcess | MHC protein complex assembly | 8.82e-05 | 21 | 86 | 3 | GO:0002396 | |
| GeneOntologyBiologicalProcess | peptide antigen assembly with MHC protein complex | 8.82e-05 | 21 | 86 | 3 | GO:0002501 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 1.32e-04 | 187 | 86 | 6 | GO:0007156 | |
| GeneOntologyCellularComponent | MHC class II protein complex | 4.70e-05 | 17 | 88 | 3 | GO:0042613 | |
| GeneOntologyCellularComponent | immunological synapse | 5.38e-05 | 49 | 88 | 4 | GO:0001772 | |
| GeneOntologyCellularComponent | MHC protein complex | 1.75e-04 | 26 | 88 | 3 | GO:0042611 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 4.28e-04 | 35 | 88 | 3 | GO:0098553 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | DHRS3 TMEM98 VPS13C HLA-DRB1 HLA-DRB4 HLA-DRB5 NUP210 VPS13A ATP11A EXT2 HMGCR LBR MAP3K5 ITPR3 | 9.72e-04 | 1293 | 88 | 14 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | DHRS3 TMEM98 VPS13C HLA-DRB1 HLA-DRB4 HLA-DRB5 NUP210 VPS13A ATP11A EXT2 HMGCR LBR MAP3K5 ITPR3 | 1.02e-03 | 1299 | 88 | 14 | GO:0098827 |
| GeneOntologyCellularComponent | lumenal side of membrane | 1.09e-03 | 48 | 88 | 3 | GO:0098576 | |
| GeneOntologyCellularComponent | nucleocytoplasmic transport complex | 1.13e-03 | 12 | 88 | 2 | GO:0031074 | |
| GeneOntologyCellularComponent | kinesin complex | 1.15e-03 | 49 | 88 | 3 | GO:0005871 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | DHRS3 TMEM98 VPS13C HLA-DRB1 HLA-DRB4 HLA-DRB5 NUP210 VPS13A ATP11A EXT2 HMGCR LBR MAP3K5 ITPR3 | 1.25e-03 | 1327 | 88 | 14 | GO:0042175 |
| Domain | MHC_II_b_N | 5.56e-06 | 8 | 88 | 3 | PD000328 | |
| Domain | MHC_II_beta | 8.32e-06 | 9 | 88 | 3 | PF00969 | |
| Domain | MHC_II_b_N | 8.32e-06 | 9 | 88 | 3 | IPR000353 | |
| Domain | MHC_II_beta | 8.32e-06 | 9 | 88 | 3 | SM00921 | |
| Domain | MHC_II_a/b_N | 3.54e-05 | 14 | 88 | 3 | IPR014745 | |
| Domain | - | 3.54e-05 | 14 | 88 | 3 | 3.10.320.10 | |
| Domain | VPS13 | 6.56e-05 | 3 | 88 | 2 | IPR026847 | |
| Domain | VPS13_mid_rpt | 6.56e-05 | 3 | 88 | 2 | PF16910 | |
| Domain | VPS13 | 6.56e-05 | 3 | 88 | 2 | PF16908 | |
| Domain | - | 6.56e-05 | 3 | 88 | 2 | 4.10.1130.10 | |
| Domain | VPS13_N2 | 6.56e-05 | 3 | 88 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 6.56e-05 | 3 | 88 | 2 | IPR031642 | |
| Domain | IG_LIKE | NPTN IGSF22 NTM HLA-DRB1 HLA-DRB4 HLA-DRB5 OBSCN FCRLB IL1R1 PTK7 | 1.04e-04 | 491 | 88 | 10 | PS50835 |
| Domain | Ig-like_dom | NPTN IGSF22 NTM HLA-DRB1 HLA-DRB4 HLA-DRB5 OBSCN FCRLB IL1R1 PTK7 | 1.26e-04 | 503 | 88 | 10 | IPR007110 |
| Domain | NEBU | 1.31e-04 | 4 | 88 | 2 | SM00227 | |
| Domain | Nebulin | 1.31e-04 | 4 | 88 | 2 | PF00880 | |
| Domain | Nebulin | 1.31e-04 | 4 | 88 | 2 | IPR013998 | |
| Domain | VPS13_C | 1.31e-04 | 4 | 88 | 2 | PF16909 | |
| Domain | SHR-BD | 1.31e-04 | 4 | 88 | 2 | IPR009543 | |
| Domain | NEBULIN | 1.31e-04 | 4 | 88 | 2 | PS51216 | |
| Domain | VPS13_C | 1.31e-04 | 4 | 88 | 2 | IPR031645 | |
| Domain | Nebulin_repeat | 1.31e-04 | 4 | 88 | 2 | IPR000900 | |
| Domain | SHR-BD | 1.31e-04 | 4 | 88 | 2 | PF06650 | |
| Domain | ATG_C | 2.17e-04 | 5 | 88 | 2 | PF09333 | |
| Domain | Autophagy-rel_C | 2.17e-04 | 5 | 88 | 2 | IPR015412 | |
| Domain | Ig_I-set | 2.78e-04 | 190 | 88 | 6 | IPR013098 | |
| Domain | I-set | 2.78e-04 | 190 | 88 | 6 | PF07679 | |
| Domain | Kinesin_assoc | 3.25e-04 | 6 | 88 | 2 | PF16183 | |
| Domain | Kinesin_assoc | 3.25e-04 | 6 | 88 | 2 | IPR032405 | |
| Domain | VPS13_N | 6.03e-04 | 8 | 88 | 2 | IPR026854 | |
| Domain | Chorein_N | 6.03e-04 | 8 | 88 | 2 | PF12624 | |
| Domain | MHC_I/II-like_Ag-recog | 7.57e-04 | 38 | 88 | 3 | IPR011162 | |
| Domain | BTK | 7.73e-04 | 9 | 88 | 2 | SM00107 | |
| Domain | Znf_Btk_motif | 7.73e-04 | 9 | 88 | 2 | IPR001562 | |
| Domain | BTK | 7.73e-04 | 9 | 88 | 2 | PF00779 | |
| Domain | ZF_BTK | 7.73e-04 | 9 | 88 | 2 | PS51113 | |
| Domain | - | NPTN IGSF22 NTM HLA-DRB1 HLA-DRB4 HLA-DRB5 OBSCN FCRLB IL1R1 PTK7 | 1.11e-03 | 663 | 88 | 10 | 2.60.40.10 |
| Domain | Cadherin_CS | 1.76e-03 | 109 | 88 | 4 | IPR020894 | |
| Domain | Ig-like_fold | NPTN IGSF22 NTM HLA-DRB1 HLA-DRB4 HLA-DRB5 OBSCN FCRLB IL1R1 PTK7 | 1.77e-03 | 706 | 88 | 10 | IPR013783 |
| Domain | RasGAP | 1.93e-03 | 14 | 88 | 2 | SM00323 | |
| Domain | RasGAP_CS | 1.93e-03 | 14 | 88 | 2 | IPR023152 | |
| Domain | CADHERIN_1 | 2.00e-03 | 113 | 88 | 4 | PS00232 | |
| Domain | Cadherin | 2.00e-03 | 113 | 88 | 4 | PF00028 | |
| Domain | CADHERIN_2 | 2.07e-03 | 114 | 88 | 4 | PS50268 | |
| Domain | - | 2.07e-03 | 114 | 88 | 4 | 2.60.40.60 | |
| Domain | C1-set | 2.11e-03 | 54 | 88 | 3 | PF07654 | |
| Domain | CA | 2.14e-03 | 115 | 88 | 4 | SM00112 | |
| Domain | Cadherin-like | 2.21e-03 | 116 | 88 | 4 | IPR015919 | |
| Domain | RasGAP | 2.21e-03 | 15 | 88 | 2 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 2.21e-03 | 15 | 88 | 2 | PS00509 | |
| Domain | RAS_GTPASE_ACTIV_2 | 2.21e-03 | 15 | 88 | 2 | PS50018 | |
| Domain | IGc1 | 2.34e-03 | 56 | 88 | 3 | SM00407 | |
| Domain | Cadherin | 2.35e-03 | 118 | 88 | 4 | IPR002126 | |
| Domain | - | 2.52e-03 | 16 | 88 | 2 | 1.10.506.10 | |
| Domain | Ig_C1-set | 2.59e-03 | 58 | 88 | 3 | IPR003597 | |
| Domain | Ig/MHC_CS | 2.59e-03 | 58 | 88 | 3 | IPR003006 | |
| Domain | IG_MHC | 2.85e-03 | 60 | 88 | 3 | PS00290 | |
| Domain | RasGAP_dom | 3.20e-03 | 18 | 88 | 2 | IPR001936 | |
| Domain | IG | 3.73e-03 | 421 | 88 | 7 | SM00409 | |
| Domain | Ig_sub | 3.73e-03 | 421 | 88 | 7 | IPR003599 | |
| Domain | - | 3.95e-03 | 20 | 88 | 2 | 3.30.565.10 | |
| Domain | HATPase_C | 4.35e-03 | 21 | 88 | 2 | IPR003594 | |
| Domain | PH | 4.56e-03 | 229 | 88 | 5 | PF00169 | |
| Pathway | BIOCARTA_BBCELL_PATHWAY | 1.88e-05 | 11 | 70 | 3 | M22030 | |
| Pathway | BIOCARTA_EOSINOPHILS_PATHWAY | 1.88e-05 | 11 | 70 | 3 | M22048 | |
| Pathway | BIOCARTA_IL5_PATHWAY | 3.24e-05 | 13 | 70 | 3 | M18928 | |
| Pathway | BIOCARTA_MHC_PATHWAY | 4.10e-05 | 14 | 70 | 3 | M22023 | |
| Pathway | BIOCARTA_TCRA_PATHWAY | 4.10e-05 | 14 | 70 | 3 | M10765 | |
| Pathway | BIOCARTA_BLYMPHOCYTE_PATHWAY | 4.10e-05 | 14 | 70 | 3 | M1473 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_NFY_MEDIATED_TRANSCRIPTION | 5.11e-05 | 15 | 70 | 3 | M47588 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_II_MOLECULES | 5.11e-05 | 15 | 70 | 3 | M47604 | |
| Pathway | BIOCARTA_ASBCELL_PATHWAY | 5.11e-05 | 15 | 70 | 3 | M7298 | |
| Pathway | BIOCARTA_CSK_PATHWAY | 1.69e-04 | 22 | 70 | 3 | M6327 | |
| Pathway | BIOCARTA_CTLA4_PATHWAY | 1.69e-04 | 22 | 70 | 3 | M1467 | |
| Pathway | BIOCARTA_TH1TH2_PATHWAY | 1.93e-04 | 23 | 70 | 3 | M6705 | |
| Pathway | REACTOME_PD_1_SIGNALING | 3.51e-04 | 28 | 70 | 3 | M18810 | |
| Pathway | BIOCARTA_INFLAM_PATHWAY | 3.91e-04 | 29 | 70 | 3 | M6910 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 3.99e-04 | 70 | 70 | 4 | M12294 | |
| Pathway | KEGG_ASTHMA | 4.32e-04 | 30 | 70 | 3 | M13950 | |
| Pathway | REACTOME_SENSORY_PROCESSING_OF_SOUND | 5.74e-04 | 77 | 70 | 4 | M41822 | |
| Pathway | KEGG_ALLOGRAFT_REJECTION | 8.07e-04 | 37 | 70 | 3 | M18615 | |
| Pathway | KEGG_HEMATOPOIETIC_CELL_LINEAGE | 9.10e-04 | 87 | 70 | 4 | M6856 | |
| Pathway | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | 9.43e-04 | 39 | 70 | 3 | M16523 | |
| Pathway | KEGG_GRAFT_VERSUS_HOST_DISEASE | 1.09e-03 | 41 | 70 | 3 | M13519 | |
| Pubmed | Recent origin of HLA-DRB1 alleles and implications for human evolution. | 1.62e-08 | 3 | 89 | 3 | 9500545 | |
| Pubmed | A novel DRB1*09 allelic sequence in the Jing ethnic minority of China. | 1.62e-08 | 3 | 89 | 3 | 12121280 | |
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 19811438 | ||
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 3099214 | ||
| Pubmed | A novel HLA-DRB1*09 allele, HLA-DRB1*090103*, isolated from the Han population of Guangdong, China. | 1.62e-08 | 3 | 89 | 3 | 15730527 | |
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 20193583 | ||
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 16441501 | ||
| Pubmed | Complete cDNA sequences of the HLA-DRB1*0402 and DRB1*11041 alleles. | 1.62e-08 | 3 | 89 | 3 | 12358860 | |
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 1428007 | ||
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 7652736 | ||
| Pubmed | Allelic diversity is generated by intraexon sequence exchange at the DRB1 locus of primates. | 1.62e-08 | 3 | 89 | 3 | 2023919 | |
| Pubmed | Shared class II MHC polymorphisms between humans and chimpanzees. | 1.62e-08 | 3 | 89 | 3 | 2511168 | |
| Pubmed | Allelic variation in the DR subregion of the human major histocompatibility complex. | 6.47e-08 | 4 | 89 | 3 | 3476943 | |
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 26740600 | ||
| Pubmed | Analysis of DR beta and DQ beta chain cDNA clones from a DR7 haplotype. | 6.47e-08 | 4 | 89 | 3 | 3020127 | |
| Pubmed | HLA-DRB alleles and systemic lupus erythematosus in Jamaicans. | 6.47e-08 | 4 | 89 | 3 | 12144077 | |
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 18520346 | ||
| Pubmed | HLA DR B1*04, *07-restricted epitopes on Keratin 17 for autoreactive T cells in psoriasis. | 6.47e-08 | 4 | 89 | 3 | 15795121 | |
| Pubmed | CNNM3 FAT1 NUP155 KRT17 VPS13C KIF1B VPS13A TMF1 MCM7 LBR EIF4G3 SLC30A1 ARAP2 | 9.23e-08 | 777 | 89 | 13 | 35844135 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | CNNM3 NPTN NUP155 XPO5 TRABD NUP210 PPIL2 KPNA6 DDX20 EXT2 LBR EIF4G3 PTK7 ITPR3 | 1.21e-07 | 942 | 89 | 14 | 31073040 |
| Pubmed | KRT17 SMCHD1 PCLO VPS13A SMARCA1 ATP11A LIMCH1 PLEC NEB EIF4G3 IL1R1 RNF17 PCK1 TOP2B DYNC1I1 PTK7 RPS6KC1 | 1.29e-07 | 1442 | 89 | 17 | 35575683 | |
| Pubmed | 1.61e-07 | 5 | 89 | 3 | 17910142 | ||
| Pubmed | 1.61e-07 | 5 | 89 | 3 | 16973583 | ||
| Pubmed | Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor. | 1.61e-07 | 5 | 89 | 3 | 1970352 | |
| Pubmed | 1.61e-07 | 5 | 89 | 3 | 7645219 | ||
| Pubmed | 1.61e-07 | 5 | 89 | 3 | 12392858 | ||
| Pubmed | 1.61e-07 | 5 | 89 | 3 | 12209103 | ||
| Pubmed | HLA-DQA is associated with abdominal aortic aneurysms in the Belgian population. | 1.61e-07 | 5 | 89 | 3 | 17182961 | |
| Pubmed | 1.61e-07 | 5 | 89 | 3 | 11782380 | ||
| Pubmed | 1.61e-07 | 5 | 89 | 3 | 23152536 | ||
| Pubmed | 1.61e-07 | 5 | 89 | 3 | 17411376 | ||
| Pubmed | Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane. | 1.61e-07 | 5 | 89 | 3 | 17507489 | |
| Pubmed | 1.61e-07 | 5 | 89 | 3 | 7734415 | ||
| Pubmed | Visual hallucinations and HLA class II antigens in cortical dementia. | 1.61e-07 | 5 | 89 | 3 | 20606439 | |
| Pubmed | HLA-DR and DQB1 gene polymorphism in the North-western Colombian population. | 1.61e-07 | 5 | 89 | 3 | 12144632 | |
| Pubmed | HIV-1 gag polyprotein rescues HLA-DR intracellular transport in a human CD4+ cell line. | 1.61e-07 | 5 | 89 | 3 | 12202216 | |
| Pubmed | CNNM3 NUP155 DOCK8 PREP HLA-DRB1 HLA-DRB5 NUP210 MCM7 KPNA6 ATP11A DDX20 EXT2 LBR FMNL1 ITPR3 | 2.66e-07 | 1168 | 89 | 15 | 19946888 | |
| Pubmed | 3.22e-07 | 6 | 89 | 3 | 17153701 | ||
| Pubmed | 3.22e-07 | 6 | 89 | 3 | 18305173 | ||
| Pubmed | 3.22e-07 | 6 | 89 | 3 | 15902698 | ||
| Pubmed | HLA risk markers for chronic myelogenous leukemia in Eastern Canada. | 3.22e-07 | 6 | 89 | 3 | 19235017 | |
| Pubmed | 3.22e-07 | 6 | 89 | 3 | 11082517 | ||
| Pubmed | 3.22e-07 | 6 | 89 | 3 | 15896200 | ||
| Pubmed | 3.22e-07 | 6 | 89 | 3 | 11997714 | ||
| Pubmed | HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. | 3.22e-07 | 6 | 89 | 3 | 14508706 | |
| Pubmed | 4.09e-07 | 24 | 89 | 4 | 18425126 | ||
| Pubmed | 5.63e-07 | 7 | 89 | 3 | 18569076 | ||
| Pubmed | 5.63e-07 | 7 | 89 | 3 | 1905983 | ||
| Pubmed | Human macrophages accumulate HIV-1 particles in MHC II compartments. | 5.63e-07 | 7 | 89 | 3 | 12230470 | |
| Pubmed | [Human leukocyte antigen genes to genetic predisposition in diffuse panbronchiolitis]. | 5.63e-07 | 7 | 89 | 3 | 18846964 | |
| Pubmed | 5.63e-07 | 7 | 89 | 3 | 20307907 | ||
| Pubmed | 8.99e-07 | 8 | 89 | 3 | 19223392 | ||
| Pubmed | Correlation between HLA and pityriasis rosea susceptibility in Brazilian blacks. | 8.99e-07 | 8 | 89 | 3 | 16405603 | |
| Pubmed | 8.99e-07 | 8 | 89 | 3 | 12296785 | ||
| Pubmed | HIV-1 capsids bind and exploit the kinesin-1 adaptor FEZ1 for inward movement to the nucleus. | 8.99e-07 | 8 | 89 | 3 | 25818806 | |
| Pubmed | 8.99e-07 | 8 | 89 | 3 | 17106278 | ||
| Pubmed | 8.99e-07 | 8 | 89 | 3 | 23729440 | ||
| Pubmed | 1.35e-06 | 9 | 89 | 3 | 24505475 | ||
| Pubmed | 1.35e-06 | 9 | 89 | 3 | 23170932 | ||
| Pubmed | 1.36e-06 | 32 | 89 | 4 | 19449444 | ||
| Pubmed | 1.92e-06 | 10 | 89 | 3 | 15784911 | ||
| Pubmed | 1.92e-06 | 10 | 89 | 3 | 12956878 | ||
| Pubmed | 1.92e-06 | 10 | 89 | 3 | 8450224 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CNNM3 NUP155 KRT17 SLC20A1 SMCHD1 NUP210 MCM7 LBR PLEC RUVBL2 TOP2B GSN ITPR3 | 2.06e-06 | 1024 | 89 | 13 | 24711643 |
| Pubmed | Polymorphism and linkage of the alpha A-crystallin gene in t-haplotypes of the mouse. | 2.63e-06 | 11 | 89 | 3 | 3036643 | |
| Pubmed | 2.63e-06 | 11 | 89 | 3 | 21085635 | ||
| Pubmed | 2.63e-06 | 11 | 89 | 3 | 22808111 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | NUP155 KRT17 RBM3 SMCHD1 POLR2C PPIL2 MCM7 KPNA6 DDX20 PLEC SLC30A1 RUVBL2 TOP2B GSN KIF1C | 2.90e-06 | 1415 | 89 | 15 | 28515276 |
| Pubmed | 5.57e-06 | 638 | 89 | 10 | 33239621 | ||
| Pubmed | HLA class II antigens and the HIV envelope glycoprotein gp120 bind to the same face of CD4. | 5.78e-06 | 14 | 89 | 3 | 7512597 | |
| Pubmed | 5.78e-06 | 14 | 89 | 3 | 17431094 | ||
| Pubmed | Interaction of CD4 with HLA class II antigens and HIV gp120. | 5.78e-06 | 14 | 89 | 3 | 1869305 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 2592019 | ||
| Pubmed | Interaction of H-2Eb with an IAP retrotransposon in the A20/2J B cell lymphoma. | 6.48e-06 | 2 | 89 | 2 | 1353478 | |
| Pubmed | Complete cDNA sequences of the HLA-DRB1*14011, *1402, *1403 and *1404 alleles. | 6.48e-06 | 2 | 89 | 2 | 11972886 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 12028548 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 3150763 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 9777332 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 3596674 | ||
| Pubmed | Isolation and characterization of a cDNA clone for the murine I-E beta polypeptide chain. | 6.48e-06 | 2 | 89 | 2 | 6324181 | |
| Pubmed | CAPRI regulates Ca(2+)-dependent inactivation of the Ras-MAPK pathway. | 6.48e-06 | 2 | 89 | 2 | 11448776 | |
| Pubmed | Mouse MHC class II gene E beta 2 is closely related to E beta and to HLA-DR beta. | 6.48e-06 | 2 | 89 | 2 | 2989167 | |
| Pubmed | Structural organization of the DR subregion of the human major histocompatibility complex. | 6.48e-06 | 2 | 89 | 2 | 3860851 | |
| Pubmed | HLA-DR2 subtypes form an additional supertypic family of DR beta alleles. | 6.48e-06 | 2 | 89 | 2 | 2885840 | |
| Pubmed | HLA-DR4 as a risk allele for autism acting in mothers of probands possibly during pregnancy. | 6.48e-06 | 2 | 89 | 2 | 19487610 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 20164547 | ||
| Pubmed | Identification of two novel HLA-DRB1 alleles, DRB1*0903 and DRB1*1145. | 6.48e-06 | 2 | 89 | 2 | 15191532 | |
| Pubmed | Identification of a novel HLA-DRB1 allele (HLA-DRB1*111902*). | 6.48e-06 | 2 | 89 | 2 | 15982264 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 15982265 | ||
| Pubmed | H2-Eb1 expression is upregulated in the nasal mucosa of allergic rhinitis. | 6.48e-06 | 2 | 89 | 2 | 25543041 | |
| Pubmed | Unique sequences for two HLA-DRB1 genes expressed on distinct DRw6 haplotypes. | 6.48e-06 | 2 | 89 | 2 | 1975801 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 15140072 | ||
| Pubmed | Detection of four novel alleles: DRB1*1130, DRB1*13072, DRB1*1315 and DRB1*1331. | 6.48e-06 | 2 | 89 | 2 | 10703621 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 20193235 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 3015788 | ||
| Pubmed | Predicted protein sequence of the murine I-E-beta S-polypeptide chain from cDNA and genomic clones. | 6.48e-06 | 2 | 89 | 2 | 2986145 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 1085338 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 15188377 | ||
| Pubmed | Complete characterization and sequence of an HLA class II DR beta chain cDNA from the DR5 haplotype. | 6.48e-06 | 2 | 89 | 2 | 3456344 | |
| Pubmed | Molecular basis for the defective expression of the mouse Ew17 beta gene. | 6.48e-06 | 2 | 89 | 2 | 2460545 | |
| Interaction | ARL10 interactions | 1.75e-06 | 189 | 88 | 8 | int:ARL10 | |
| Interaction | RHOF interactions | CNNM3 FAT1 NUP155 XPO5 DOCK8 TRABD VPS13A ATP11A LBR SLC30A1 FMNL1 TOP2B | 3.52e-05 | 673 | 88 | 12 | int:RHOF |
| Interaction | CDC42 interactions | CNNM3 FAT1 NUP155 DOCK8 TRABD POLR2C NUP210 VPS13A MCM7 ATP11A LBR SLC30A1 FMNL1 TOP2B DYNC1I1 ARAP2 ITPR3 | 5.04e-05 | 1323 | 88 | 17 | int:CDC42 |
| Interaction | RAC1 interactions | CNNM3 FAT1 NUP155 XPO5 DOCK8 SLC20A1 TRABD VPS13A KPNA6 ATP11A LBR SLC30A1 FMNL1 DYNC1I1 ARAP2 | 5.23e-05 | 1063 | 88 | 15 | int:RAC1 |
| Interaction | NBEAL1 interactions | 5.23e-05 | 17 | 88 | 3 | int:NBEAL1 | |
| Interaction | RHOA interactions | ACE2 CNNM3 FAT1 NUP155 VPS13C TRABD POLR2C NUP210 VPS13A ATP11A LBR SLC30A1 FMNL1 TOP2B ARAP2 ITPR3 | 5.56e-05 | 1199 | 88 | 16 | int:RHOA |
| Interaction | LMBR1L interactions | CNNM3 NPTN NUP155 XPO5 TRABD NUP210 PPIL2 KPNA6 DDX20 EXT2 LBR EIF4G3 PTK7 ITPR3 | 5.76e-05 | 946 | 88 | 14 | int:LMBR1L |
| Interaction | HRAS interactions | ACE2 CNNM3 NPTN KRT17 DHRS3 XPO5 DOCK8 RASA4 ATP11A SLC30A1 ARAP2 PTK7 | 7.20e-05 | 725 | 88 | 12 | int:HRAS |
| Interaction | CUL7 interactions | NUP155 KRT17 DCAF8L1 SLC20A1 SMCHD1 NUP210 MCM7 LBR PLEC RUVBL2 TOP2B GSN KIF1C | 7.39e-05 | 845 | 88 | 13 | int:CUL7 |
| Interaction | RHOJ interactions | CNNM3 FAT1 DOCK8 VPS13C VPS13A ATP11A LBR SLC30A1 FMNL1 TOP2B PTK7 | 9.61e-05 | 633 | 88 | 11 | int:RHOJ |
| Cytoband | 7q21.3-q22.1 | 3.70e-05 | 5 | 89 | 2 | 7q21.3-q22.1 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.15e-05 | 161 | 68 | 6 | 593 | |
| GeneFamily | C1-set domain containing | 5.26e-04 | 42 | 68 | 3 | 591 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 6.03e-04 | 44 | 68 | 3 | 588 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 6.15e-04 | 10 | 68 | 2 | 830 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 6.88e-04 | 46 | 68 | 3 | 622 | |
| GeneFamily | Cadherin related | 1.83e-03 | 17 | 68 | 2 | 24 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 3.95e-03 | 25 | 68 | 2 | 504 | |
| GeneFamily | Immunoglobulin like domain containing | 6.02e-03 | 193 | 68 | 4 | 594 | |
| GeneFamily | Nucleoporins | 6.43e-03 | 32 | 68 | 2 | 1051 | |
| Coexpression | GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN | 5.10e-06 | 200 | 88 | 7 | M5286 | |
| Coexpression | GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP | 3.28e-05 | 180 | 88 | 6 | M6718 | |
| Coexpression | ALCALAY_AML_BY_NPM1_LOCALIZATION_DN | 3.94e-05 | 186 | 88 | 6 | M19867 | |
| Coexpression | SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_1DY_UP | 4.66e-05 | 21 | 88 | 3 | M41167 | |
| Coexpression | GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_DN | 5.27e-05 | 196 | 88 | 6 | M5791 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_14_PRECICTIVE_ICB_RESPONSE | 5.58e-05 | 198 | 88 | 6 | MM17083 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDC_UP | 5.74e-05 | 199 | 88 | 6 | M3972 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 3.41e-09 | 185 | 88 | 8 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 8.82e-08 | 186 | 88 | 7 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.45e-07 | 200 | 88 | 7 | 80e0483d5ab0c6213aae0ec62619f57e6ec0e4c2 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 1.28e-06 | 174 | 88 | 6 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-DC-cDC2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.66e-06 | 182 | 88 | 6 | 1d37c486173cc4629842893ddd5033987c04086f | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-DC-cDC2-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.66e-06 | 182 | 88 | 6 | aef67bdc6937b315522d39959e26c9b0acf7ab52 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-DC|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.66e-06 | 182 | 88 | 6 | 087c9f88daf08f5d688b728c2386f91f210d2255 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 184 | 88 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.77e-06 | 184 | 88 | 6 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 184 | 88 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 184 | 88 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.77e-06 | 184 | 88 | 6 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | PCW_13-14-Immune_Lymphocytic-Immune_Lymphocytic_B-im_B_cell_(15)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.83e-06 | 185 | 88 | 6 | 8fc357ee041bfd588986730a52ea2021b5f88941 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-06 | 192 | 88 | 6 | 0dc1f46e40346ed0b286e53b106a812441575100 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-06 | 195 | 88 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-06 | 195 | 88 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.55e-06 | 196 | 88 | 6 | 6731fef8c148b6681d6ed38afdf23c8213e0bbbe | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.55e-06 | 196 | 88 | 6 | 6856317cd0cdcb88fe54b4ae905d91e13495b1c4 | |
| ToppCell | PBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | 2.55e-06 | 196 | 88 | 6 | 09d197b321ff9f13c0672ea059c850845b0dbbd5 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 2.78e-06 | 199 | 88 | 6 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | Biopsy_IPF-Epithelial-Transitional_AT2|Biopsy_IPF / Sample group, Lineage and Cell type | 2.78e-06 | 199 | 88 | 6 | 83ff8b7e472d1212324c05cc719b746d19e5e23b | |
| ToppCell | Biopsy_Other_PF-Epithelial-Transitional_AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.86e-06 | 200 | 88 | 6 | 1ba6327851aa61e9a1f1fe1671bc27929d93ac74 | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 2.86e-06 | 200 | 88 | 6 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 152 | 88 | 5 | b61d2f6ee819c8dd4b4b601a8bc8388b1983de58 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.75e-05 | 162 | 88 | 5 | 4d13c271b4f63cf32980e5643b5d5951165fe8b5 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.15e-05 | 169 | 88 | 5 | cfc9ff103d13a2d5eacc457e800f53fdd29f7738 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.34e-05 | 172 | 88 | 5 | ac20766d1fd43eab8c3ff5e7418a6b38bebf0bd5 | |
| ToppCell | (07)_Ionocytes-(2)_GFP_FOXI1|(07)_Ionocytes / shred by cell type by condition | 2.34e-05 | 172 | 88 | 5 | 5776b638b845d054f6e884e7df0412477f48517d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.34e-05 | 172 | 88 | 5 | 3fd1bc4a8ced0bf9e26ca4ce6d83b5b97bbc2556 | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.68e-05 | 177 | 88 | 5 | c5e829bc4594761666d65cace5a9c5d19c16f187 | |
| ToppCell | 3'_v3-Lung-Hematopoietic_progenitors-HSC-MPP|Lung / Manually curated celltypes from each tissue | 2.83e-05 | 179 | 88 | 5 | 2c03b82ec9b4dee2501752b8d83e7028f0aaed77 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_conventional_dendritic_(19)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.83e-05 | 179 | 88 | 5 | 9fc44637c9a7551fd47b8533e45a9c199e164a95 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-05 | 180 | 88 | 5 | c54af6fb11484dacd3efa1f10a487376ff820a5e | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-05 | 180 | 88 | 5 | 07ac979b21be2425294d9818c48b5a1e6f014c19 | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_B-im_B_cell_(15)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.98e-05 | 181 | 88 | 5 | 51e4d6bfdbf414d8e30aee2e6f7492f4f7f54373 | |
| ToppCell | 3'_v3-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue | 2.98e-05 | 181 | 88 | 5 | 66d890a105f955dca91d6e5e6c730d1a68ee9233 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-05 | 182 | 88 | 5 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 182 | 88 | 5 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 182 | 88 | 5 | bc8d621be57f76d718d9b0f11e023b0f4dcb668d | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.14e-05 | 183 | 88 | 5 | a644258ba90acc62d571623e429d72ffc4b69203 | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 3.14e-05 | 183 | 88 | 5 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 3.22e-05 | 184 | 88 | 5 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 184 | 88 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 3.22e-05 | 184 | 88 | 5 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-05 | 185 | 88 | 5 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-05 | 186 | 88 | 5 | 4ae3c0fe8640a8d029875cf3f0f5ffbba38e85f8 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 3.48e-05 | 187 | 88 | 5 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-Activated_T|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.66e-05 | 189 | 88 | 5 | c38157c8cf5c0c1f560011ef5cc5892a049ee2b7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 3.66e-05 | 189 | 88 | 5 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.76e-05 | 190 | 88 | 5 | ad297172a74a80ed5c10f921e15efd1da0fd2d6b | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.85e-05 | 191 | 88 | 5 | 8a73d2df079566fca4cbb5cdb85721c2e87134c8 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 3.85e-05 | 191 | 88 | 5 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.85e-05 | 191 | 88 | 5 | ce80f65bd24b1c4d2152bf45248449e7a1a97e56 | |
| ToppCell | droplet-Lung-21m-Mesenchymal|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.85e-05 | 191 | 88 | 5 | 10a9db1caa0fdb51ace8537f42b2c66f7c97e0f5 | |
| ToppCell | COVID-19-kidney-Myeloid|kidney / Disease (COVID-19 only), tissue and cell type | 3.95e-05 | 192 | 88 | 5 | 441cd1ec171f643b28e1f6f9c04def629cc7391b | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 3.95e-05 | 192 | 88 | 5 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | IPF-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 3.95e-05 | 192 | 88 | 5 | 356e7a820b744a0ac87352a8d0e6e8d9fa9ed7d2 | |
| ToppCell | AT1_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 3.95e-05 | 192 | 88 | 5 | 0444f9e9cef7403e220e862b5a787443d3f5c9ac | |
| ToppCell | COVID-19-kidney-Myeloid|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.95e-05 | 192 | 88 | 5 | 0b9d22a222f1201e375f8e55cace9ef939febae4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.05e-05 | 193 | 88 | 5 | daefbfd3a3dd1351fbe94b9abfd807db44d56c24 | |
| ToppCell | COVID-19-lung-CD4+_T_cells_metabolically_active|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.05e-05 | 193 | 88 | 5 | 326fd2ce2c4b51e5a38f2a7a09f22f8f0e92735a | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-05 | 193 | 88 | 5 | a6a864644e1b80b7417ea0a27281e79068a3fd3d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.05e-05 | 193 | 88 | 5 | b52d5661edff83ac4c5fe2bf89d6672016bb827b | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-DC2|Lung / Manually curated celltypes from each tissue | 4.05e-05 | 193 | 88 | 5 | c97f9b13057f803df63c696c6175ef8e0aba6fa7 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.15e-05 | 194 | 88 | 5 | 43eb677a76634bb9a48a40e0d607c4936ae64bcc | |
| ToppCell | AT2_cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 4.25e-05 | 195 | 88 | 5 | 0792c1e959e933b10ae987d821ff43020dfdabad | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.25e-05 | 195 | 88 | 5 | 62dc745e1aa3e2e58afa16c7bb2cf9b03d4e8105 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.25e-05 | 195 | 88 | 5 | 68f4cc84b5ae7f4159b780c78e4b66c94211779a | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.25e-05 | 195 | 88 | 5 | 79114b3c78cc15c413bb58f0673e7215b784a9b6 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.25e-05 | 195 | 88 | 5 | 2a1863f4b9fe73c30b0b1acf9b12fc98ef65040f | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-05 | 196 | 88 | 5 | 34e79918a448f6c19b87e1b1ce13c012b24be1f8 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-05 | 196 | 88 | 5 | 8f82e01ca50aa4cd6149547505b4474a02fad618 | |
| ToppCell | Leuk-UTI-Myeloid-cDC2|Leuk-UTI / Disease, Lineage and Cell Type | 4.36e-05 | 196 | 88 | 5 | 50465a082f03201936733c55af73bc32e1bdd024 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Club|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.36e-05 | 196 | 88 | 5 | d5f9168001e60bafec17fe6c702e68f5528edc20 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.36e-05 | 196 | 88 | 5 | eb68f7954e7c2f86d05e740e95b6e74805a6053f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.36e-05 | 196 | 88 | 5 | e54c08f88779f9fd453a4f5b85aed1f460d8a1e1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.46e-05 | 197 | 88 | 5 | b597c292fc1cb381a4325fed15a32966c38def28 | |
| ToppCell | Enterocyte|World / shred on cell type and cluster | 4.46e-05 | 197 | 88 | 5 | 1dd980fd066aef21694395a4b69df938501d9631 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 4.46e-05 | 197 | 88 | 5 | 6b6504c47c309bac4f790e2f372d454bbdea49e8 | |
| ToppCell | ASK428-Epithelial-Type_1|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.46e-05 | 197 | 88 | 5 | 9ae6661c307791c3f0ecd3d378e3d917565e5498 | |
| ToppCell | Biopsy_IPF-Epithelial-AT1|Biopsy_IPF / Sample group, Lineage and Cell type | 4.57e-05 | 198 | 88 | 5 | 75bdecbe111fededf6082b11de18b84ca308ef6d | |
| ToppCell | C_01|World / shred on cell type and cluster | 4.57e-05 | 198 | 88 | 5 | 71d38084d09a96331877384ce6346f0de4bdcef9 | |
| ToppCell | ASK428-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.57e-05 | 198 | 88 | 5 | 0047a9ef7684230ac5179efea94461480e90bdaf | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-iNKT-MAIT|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.68e-05 | 199 | 88 | 5 | c23a53a20487a8abfeb91fa5fc9c06823dd657e9 | |
| ToppCell | Endothelial_cells-Endothelial-A|Endothelial_cells / lung cells shred on cell class, cell subclass, sample id | 4.68e-05 | 199 | 88 | 5 | 2a1424c61ddcd1fea9574f7a3ad1955387458130 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.68e-05 | 199 | 88 | 5 | b0a906586e58009f5ed9272fc29ba28e49c85ee6 | |
| ToppCell | (00)_Basal-(1)_GFP|(00)_Basal / shred by cell type by condition | 4.68e-05 | 199 | 88 | 5 | 105b15157f35df3fdf857e306f11e4e8200e05d4 | |
| ToppCell | COVID-19-COVID-19_Severe-Others-HSPC|COVID-19_Severe / Disease, condition lineage and cell class | 4.68e-05 | 199 | 88 | 5 | 25de67b6c9c8d6bb9a538e071a40ef865906c95d | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.68e-05 | 199 | 88 | 5 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.68e-05 | 199 | 88 | 5 | 5ceeed92f831d068ff4bb3994f420002338330e7 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.68e-05 | 199 | 88 | 5 | b7af2b4fe6866cc8c78cf0f78390aab1b1b389ba | |
| ToppCell | ASK428-Epithelial|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.68e-05 | 199 | 88 | 5 | ba2aaaeb4d9b448a6b9660b152fcac1a0e3fcfe7 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.68e-05 | 199 | 88 | 5 | e6715288a586631676722f2323f0d833431161cf | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.68e-05 | 199 | 88 | 5 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | 21|World / Age, Tissue, Lineage and Cell class | 4.68e-05 | 199 | 88 | 5 | 8c6517243168de4134e06dbe16ca89b1c2a73179 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_basal-Dividing_Basal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.68e-05 | 199 | 88 | 5 | f0c289523957258d16135c04679db379d43d28d9 | |
| ToppCell | proximal|World / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.79e-05 | 200 | 88 | 5 | 33f05ed458c889bf241580f513ce66797007248c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 4.79e-05 | 200 | 88 | 5 | 84e4565d28a02700bf7f6730d1b3a58744ca0aea | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 4.79e-05 | 200 | 88 | 5 | 1decf1d2cba5ebfd3e5cd4bcd637db8f193033ce | |
| ToppCell | Sigmoid-Macrophage-Macrophage|Sigmoid / Region, Cell class and subclass | 4.79e-05 | 200 | 88 | 5 | 9ee3a799de7bade1bfe94b6827461633f02bc1dc | |
| Drug | Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.98e-08 | 180 | 87 | 9 | 2859_DN | |
| Drug | Palladium | 1.87e-06 | 7 | 87 | 3 | ctd:D010165 | |
| Drug | Dipivefrin hydrochloride [64019-93-8]; Up 200; 10.4uM; PC3; HT_HG-U133A | 7.83e-06 | 188 | 87 | 7 | 7124_UP | |
| Drug | Megestrol acetate [595-33-5]; Up 200; 10.4uM; HL60; HT_HG-U133A | 9.94e-06 | 195 | 87 | 7 | 3091_UP | |
| Drug | Progesterone [57-83-0]; Up 200; 12.8uM; HL60; HT_HG-U133A | 9.94e-06 | 195 | 87 | 7 | 2426_UP | |
| Drug | Norgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.06e-05 | 197 | 87 | 7 | 4730_UP | |
| Disease | Hantavirus hemorrhagic fever with renal syndrome (is_implicated_in) | 8.79e-06 | 2 | 88 | 2 | DOID:11266 (is_implicated_in) | |
| Disease | Parkinson's disease 23 (implicated_via_orthology) | 8.79e-06 | 2 | 88 | 2 | DOID:0060896 (implicated_via_orthology) | |
| Disease | choreaacanthocytosis (implicated_via_orthology) | 8.79e-06 | 2 | 88 | 2 | DOID:0050766 (implicated_via_orthology) | |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 2.63e-05 | 3 | 88 | 2 | DOID:0111611 (implicated_via_orthology) | |
| Disease | acute disseminated encephalomyelitis (is_implicated_in) | 2.63e-05 | 3 | 88 | 2 | DOID:639 (is_implicated_in) | |
| Disease | Cohen syndrome (implicated_via_orthology) | 2.63e-05 | 3 | 88 | 2 | DOID:0111590 (implicated_via_orthology) | |
| Disease | Allergic Reaction | 3.85e-05 | 63 | 88 | 4 | C1527304 | |
| Disease | Hypersensitivity | 4.09e-05 | 64 | 88 | 4 | C0020517 | |
| Disease | bacterial infectious disease (is_implicated_in) | 5.26e-05 | 4 | 88 | 2 | DOID:104 (is_implicated_in) | |
| Disease | choreatic disease (is_implicated_in) | 8.74e-05 | 5 | 88 | 2 | DOID:12859 (is_implicated_in) | |
| Disease | hepatocyte nuclear factor 4-alpha measurement | 8.74e-05 | 5 | 88 | 2 | EFO_0801672 | |
| Disease | severe acute respiratory syndrome (is_implicated_in) | 1.83e-04 | 7 | 88 | 2 | DOID:2945 (is_implicated_in) | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 2.43e-04 | 8 | 88 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | interleukin-21 measurement | 2.43e-04 | 8 | 88 | 2 | EFO_0801724 | |
| Disease | FEV/FEC ratio | NPTN NEBL NTM VPS13C KIF1B NEURL1 CDH23 MCM7 NEB DENND3 TOP2B ARAP2 | 2.83e-04 | 1228 | 88 | 12 | EFO_0004713 |
| Disease | Epstein Barr virus nuclear antigen 1 IgG measurement | 3.12e-04 | 9 | 88 | 2 | EFO_0007790 | |
| Disease | central nervous system non-hodgkin lymphoma | 3.12e-04 | 9 | 88 | 2 | MONDO_0044887 | |
| Disease | HLA class II histocompatibility antigen, DQ alpha 2 chain measurement | 3.12e-04 | 9 | 88 | 2 | EFO_0801686 | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 3.32e-04 | 45 | 88 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 3.32e-04 | 45 | 88 | 3 | EFO_0004623, EFO_0004792 | |
| Disease | conotruncal heart malformations | 3.84e-04 | 114 | 88 | 4 | MONDO_0016581 | |
| Disease | CCL19 measurement | 3.90e-04 | 10 | 88 | 2 | EFO_0009415 | |
| Disease | autosomal dominant nonsyndromic deafness (is_implicated_in) | 4.75e-04 | 11 | 88 | 2 | DOID:0050564 (is_implicated_in) | |
| Disease | aspirin-induced respiratory disease (is_implicated_in) | 4.75e-04 | 11 | 88 | 2 | DOID:0080822 (is_implicated_in) | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 4.81e-04 | 51 | 88 | 3 | cv:CN043650 | |
| Disease | nervous system disease (implicated_via_orthology) | 5.69e-04 | 12 | 88 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | anti-Epstein Barr virus antibody measurement | 5.69e-04 | 12 | 88 | 2 | EFO_0009273 | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 6.34e-04 | 56 | 88 | 3 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | fibrinogen measurement, factor VII measurement | 7.02e-04 | 58 | 88 | 3 | EFO_0004619, EFO_0004623 | |
| Disease | PR interval | 7.06e-04 | 495 | 88 | 7 | EFO_0004462 | |
| Disease | platelet-to-lymphocyte ratio | 7.72e-04 | 363 | 88 | 6 | EFO_0008446 | |
| Disease | C-C motif chemokine 19 measurement | 7.82e-04 | 14 | 88 | 2 | EFO_0008047 | |
| Disease | Stuttering | 9.00e-04 | 143 | 88 | 4 | HP_0025268 | |
| Disease | anti-anoctamin 2 antibody measurement | 1.16e-03 | 17 | 88 | 2 | EFO_0010150 | |
| Disease | response to interferon-beta, anti-drug antibody measurement | 1.16e-03 | 17 | 88 | 2 | EFO_0010559, GO_0035456 | |
| Disease | nevus count | 1.30e-03 | 18 | 88 | 2 | EFO_0004632 | |
| Disease | late-onset myasthenia gravis | 1.30e-03 | 18 | 88 | 2 | EFO_1001490 | |
| Disease | cytomegalovirus virus reactivation, response to allogeneic hematopoietic stem cell transplant | 1.45e-03 | 19 | 88 | 2 | EFO_0007044, EFO_0020106 | |
| Disease | Nonsyndromic genetic hearing loss | 1.54e-03 | 76 | 88 | 3 | cv:C5680182 | |
| Disease | susceptibility to strep throat measurement | 1.54e-03 | 76 | 88 | 3 | EFO_0008408 | |
| Disease | Nonsyndromic Deafness | 1.85e-03 | 81 | 88 | 3 | C3711374 | |
| Disease | Henoch-Schoenlein purpura | 1.95e-03 | 22 | 88 | 2 | EFO_1000965 | |
| Disease | ubiquitin carboxyl-terminal hydrolase 25 measurement | 1.95e-03 | 22 | 88 | 2 | EFO_0021881 | |
| Disease | risk-taking behaviour | 2.03e-03 | 764 | 88 | 8 | EFO_0008579 | |
| Disease | type 1 diabetes mellitus (is_implicated_in) | 2.12e-03 | 85 | 88 | 3 | DOID:9744 (is_implicated_in) | |
| Disease | skin aging measurement | 2.14e-03 | 181 | 88 | 4 | EFO_0008006 | |
| Disease | liver fibrosis measurement | 2.19e-03 | 86 | 88 | 3 | EFO_0010576 | |
| Disease | Liver Cirrhosis, Experimental | 2.20e-03 | 774 | 88 | 8 | C0023893 | |
| Disease | non-Hodgkins lymphoma | 2.52e-03 | 25 | 88 | 2 | EFO_0005952 | |
| Disease | multisite chronic pain | 2.91e-03 | 95 | 88 | 3 | EFO_0010100 | |
| Disease | Nephrotic Syndrome | 2.94e-03 | 27 | 88 | 2 | C0027726 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VRLVKRDVRTPFAVE | 91 | Q3I5F7 | |
| VTTQRTFVFRVEKEE | 546 | Q8WZ64 | |
| VRNKVIEQRVPVLAS | 631 | Q9UHI6 | |
| SVRFVIDVGVERRKV | 351 | Q7L7V1 | |
| VVQVRIPSRVDKSES | 211 | Q8NEG7 | |
| TDIRIFPTDLVKRTV | 586 | A2RUS2 | |
| EFVISPVEGVLRVRK | 1791 | Q9H251 | |
| QRVKEDHTRVVSPII | 226 | Q8N428 | |
| IVKVDNEPIIRTATV | 31 | O43374 | |
| PISEVVVVKDRETQR | 31 | P98179 | |
| RPKEEIRIDATTVFV | 421 | Q13356 | |
| DPRDVARIESKTVIV | 81 | P35558 | |
| KTVIVTQEQRDTVPI | 91 | P35558 | |
| IVKVDNEPIIRTATV | 31 | C9J798 | |
| KEAFAIVSVPVSEIR | 426 | Q14573 | |
| ELAVRTFEVTPIRAK | 191 | Q14739 | |
| IKISEFRVVVARIGT | 981 | Q7RTW8 | |
| AIAIPVTVAFVVDRR | 1776 | Q8TEM1 | |
| AREEPQLFSTVVVKV | 901 | Q14517 | |
| IDEVINTPRVVDRFV | 116 | O60684 | |
| VDSSRSVRPVEFEKV | 46 | P21941 | |
| ESFTVQRRVEPKVTV | 116 | Q30154 | |
| DVAAPVVRRVKVTVN | 206 | Q9P121 | |
| KVTARVVSRRNPEDV | 31 | Q96S38 | |
| VVCEAVIPAKVVREV | 706 | P04035 | |
| VKVAVRVRPFNSRET | 6 | O60333 | |
| SKVTQVDFLPREVVS | 151 | O14576 | |
| TPSIRARVDAKVEII | 3536 | Q9Y6V0 | |
| QADRRAFTVPTIVVE | 206 | Q6NV75 | |
| VKVAVRVRPFNARET | 6 | O43896 | |
| FSKVDFIIIVPRSEV | 701 | Q9C091 | |
| VTVRGIVTRVSEVKP | 161 | P33993 | |
| ARTIDRSVFKPIVQI | 331 | O75694 | |
| TSARLEVRVKPVVFL | 2636 | Q5VST9 | |
| PTDAVKQRVVVVVRD | 626 | Q9H158 | |
| ELEPRVFREVTVKGI | 416 | P48147 | |
| HVKRRVQDVISPIVF | 561 | Q13797 | |
| PVKVTERQTAVFEIR | 336 | Q8N9C0 | |
| EPVTTRQVRTIVEEV | 401 | Q04695 | |
| RISVIQKEEFVLTPI | 1931 | Q8NF50 | |
| NPKETTRVAVFVRIL | 466 | Q9Y6N8 | |
| ESFTVQRRVQPKVTV | 116 | P01911 | |
| VSDIIPRTEVEKAIR | 691 | Q9BYF1 | |
| ESFTVQRRVQPKVTV | 116 | P13762 | |
| EDIITVIKTVPFTAR | 1066 | O95466 | |
| IRVSVEVEKPREELF | 166 | P50053 | |
| LRQDRPASKVVVTRE | 316 | A6NGE4 | |
| QVKGRRVVRATEVPV | 191 | P06396 | |
| VAVTVQELFRAPVLR | 186 | Q6BAA4 | |
| RVPSEVVKQRAQVSA | 106 | Q70HW3 | |
| VPLQAVVEERTVSFK | 306 | Q8WUM9 | |
| TFRVDTAVIKQRVPI | 1481 | O43432 | |
| RVIEFITLEENKPTR | 211 | P14778 | |
| VDSVKAVRVRPFSQR | 6 | B7ZC32 | |
| LKPETVARRTVEAVQ | 241 | O75911 | |
| ERKIIEDTVVPFTVS | 821 | Q9UPQ0 | |
| LVEATKTDVTVVRFP | 546 | Q99683 | |
| ATTKVPEIRDVTRIE | 6 | Q9Y230 | |
| VRTVPIAKLDRTVAE | 661 | A6NHR9 | |
| TTDFVDEVRAIIPRV | 186 | P78345 | |
| PVRVFRLITDNTVEE | 616 | P28370 | |
| VVDRNTVEITELPVR | 936 | Q02880 | |
| ETRKQVTFLIVFPIV | 466 | Q9UI40 | |
| FVVPRTVNVEDTIKL | 676 | Q7Z443 | |
| ANSIRRVFIAEVPII | 31 | P19387 | |
| SGDKIVVVVRDRPFQ | 176 | Q9H190 | |
| VVVVRDRPFQRTVTM | 181 | Q9H190 | |
| REVDVFSPLRISEKV | 506 | Q8NE01 | |
| SIFPRVIEGKVDQIR | 581 | P98196 | |
| VSEFQEKILEPRTTR | 1156 | Q9BXT8 | |
| VAVFIGQPTEVVKVR | 126 | P25874 | |
| ITKPVRRTVVDESEN | 81 | P82094 | |
| RIIFAEKQVIPTRES | 66 | I1YAP6 | |
| AQIVVPVTFRDVTVI | 56 | Q6P1L6 | |
| QRIILFTEDPRVFKV | 2496 | Q96RL7 | |
| PVRVAETIFVKVTRS | 331 | O76050 | |
| VVKTIREVQPDVVVV | 91 | Q9H4I3 | |
| VESLFRVITEVSKVP | 466 | Q93063 | |
| QKPRIVTSEEVIIRD | 146 | Q9Y639 | |
| VEESKAPRTRAVRNV | 586 | Q9HAV4 | |
| ETVRVRKVDVSSVPD | 1901 | Q709C8 | |
| VQFLRRPKTITRVFE | 16 | O95473 | |
| SSVRKRRVVIVDPET | 4271 | Q15149 | |
| RRTKAENIPAVVIEI | 481 | Q9Y6M5 | |
| TVRVPEQVFVADLVT | 121 | Q9Y462 | |
| LTVAVFITFKVEPER | 586 | Q13308 | |
| IVFKDVRAQRPIRST | 111 | O14544 | |
| SDIIVVAKRISPRVD | 126 | Q9Y2Y6 | |
| TIIRPNTVEKATDVR | 661 | Q8NEV4 | |
| VDDPVTERVRKNTQV | 801 | O76041 | |
| TTVTPEIERVKRNQE | 6226 | P20929 |